The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 7, 1998, Pages 571-577

  Dallinga, Jan W ^a   Pachen, Danielle M F A ^a   Wijnhoven, Suzanne W P ^a   Breedijk, Annette ^b   Van 't Veer, Laura ^b   Wigbout, Gea ^b   Van Zandwijk, Nico ^b   Maas, Lou M ^a   Van Agen, Ebienus ^a   Kleinjans, Jos C S ^a   Van Schooten, Frederik Jan ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBIPHENYLHEMOGLOBIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ACETYLATION; ADULT; ARTICLE; BINDING AFFINITY; CIGARETTE SMOKING; DNA ADDUCT; DNA DETERMINATION; DOSIMETRY; FEMALE; GENETIC POLYMORPHISM; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AMINOBIPHENYL COMPOUNDS; ARYLAMINE N-ACETYLTRANSFERASE; BIOLOGICAL MARKERS; DNA ADDUCTS; FEMALE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN A; HUMANS; LYMPHOCYTES; MALE; PHENOTYPE; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; SMOKING;

EID: 7344262309     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bryant, M S., Skipper, P. L., Tannenbaum, S. R , and Maclure, M Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers Cancer Res., 47: 602-608, 1987.
2. Falter, B., Kutzer, C., and Richter, E Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines Clin. Invest., 72: 364-371, 1994
3. Vineis, P , Talaska, G , Malaveille, C , Barisch, H , Martone, T., Sithisarankul, P , and Strickland, P DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int. J. Cancer, 65: 314-316, 1996.
4. Bryant, M S., Vineis, P., Skipper, P. L , and Tannenbaum, S. R. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc. Natl Acad Sci. USA, 85: 9788-9791, 1988.
5. Bartsch, H., Caporaso, N., Coda, M., Kadlubar, F., Malaveille, C., Skipper, P., Talaska, G , Tannenbaum, S. R., and Vineis, P. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J. Natl Cancer Inst (Bethesda), 82. 1826-1831, 1990.
6. Yu, M. C , Skipper, P L., Taghizadeh, K., Tannenbaum, S R , Chan, K. K., Henderson, B. E , and Ross, R K Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California J. Natl. Cancer Inst (Bethesda), 86: 712-716, 1994.
7. IARC. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking, Vol. 38. Lyon, France: IARC, 1986
8. Bartsch, H., Malaveille, C., Friesen, M , Kadlubar, F , and Vineis, P. Black (air-cured) and blond (flue-cured) tobacco cancer risk IV, molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J Cancer, 29A: 1199-1207, 1993
9. Schut, H. A J., and Shiverick, K T. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. FASEB J., 6. 2942-2951, 1992.
10. Cuzick, J , Routledge, M. N., Jenkins, D , and Garner, R C DNA adducts in different tissues of smokers and non-smokers Int. J. Cancer, 45. 673-678, 1990
11. Phillips, D. H , Schoket, B., Hewer, A., Bailey, E , Kostic, S , and Vincze, I Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells Int. J Cancer, 46: 569-575, 1990.
12. Van Maanen, J. M S., Maas, L. M , Hageman. G., Kleinjans, J C. S , and Van Agen, B. DNA adduct and mutation analysis in white blood cells, of smokers and nonsmokers. Environ. Mol. Mutagenesis, 24: 46-50, 1994.
13. 32P-postlabeling analysis. Carcinogenesis (Lond.), 11. 205-211, 1990.
14. 32P-Post-labelling analysis of DNA adducts in monocytes of smokers and passive smokers. Int. Arch Occup. Environ. Health, 62: 299-303, 1990.
15. 32P-postlabelling assay. Carcinogenesis (Lond.), 12. 503-508, 1991.
16. Izotti, A., Rossi, G. A , Bagnasco, M , and De Flora, S. Benzo(a)pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers Carcinogenesis (Lond.), 12: 1281-1285, 1991.
17. De Flora, S , Izotti, A., D'Agostini, F, Rossi, G A , and Balansky, R. M. Pulmonary alveolar macrophages in molecular epidemiology and chemoprevention of cancer. Environ. Health Perspect., 99. 249-252, 1993.
18. Yu, M C, Ross, R. K., Chan, K K., Henderson, B. E., Skipper, P. L., Tannenbaum, S R., and Coetzee, G A. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black, and Asian smokers and nonsmokers. Cancer Epidemiol. Biomark. Prev , 4: 861-864, 1995.
19. Hou, S-M., Lambert, B , and Hemminki, K. Relationship between hpri mutant frequency, aromatic DNA adducts and genotypes for CSTMI and NAT2 in bus maintenance workers. Carcinogenesis (Lond.), 16: 1913-1917, 1995.
20. Nielsen, P. S., De Pater, N., Okkels, H., and Autrup, H. Environmental air pollution and DNA adducts in Copenhagen bus drivers' effect of GSTMI and NAT2 genotypes on adduct levels. Carcinogenesis (Lond.), 17: 1201-1027, 1996.
21. Hecht, S. S., Carmella, S. G , and Murphy, S. E. Tobacco-specific nitrosamine-hemoglobin adducts In: J. Everse, K D. Vandegriff and R. M Winslow (eds.), Methods in Enzymology, Vol. 231. pp. 657-667. San Diego, CA: Academic Press, 1994
22. Skipper, P L , and Stillwell, W. G. Aromatic hemoglobin adducts. In: J. Everse, K. D. Vandegnff and R. M Winslow (eds.), Methods in Enzymology, Vol. 231, pp. 643-649 Academic Press. 1994
23. Bøyum, A. Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol., 5: 9-15, 1976.
24. 32P-postlabeling test for structurally diverse DNA adducts Carcinogenesis (Lond.), 7: 1543-1551, 1986
25. 32P-Postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. Mutat. Res., 378: 65-75, 1997
26. Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R., and Spurr, N. K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer Carcinogenesis (Lond.), 14: 1821-1824, 1993.
27. Doll, M. A , Fretland, A J . Deitz, A. C., and Hein, D. W. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Anal. Biochem , 321: 413-420, 1995.
28. Lin, H. J., Han, C-Y., Lin, B. K , and Hardy, S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology. Am. J. Hum. Genet., 52: 827-834, 1993.
29. Tannenbaum, S R. Hemoglobin-carcinogen adducts as molecular bromarkers in epidemiology. Princess Takamatsu Symp , 21 351-360, 1991.
30. Djordjevic, M. V., Fan, J., Ferguson, S., and Hoffmann, D. Self-regulation of smoking intensity Smoke yields of the low-nicotine, low-"tar" cigarettes. Carcinogenesis (Lond), 16: 2015-2021, 1995.
31. Hee, J., Callais, F, Momas, I., Laurent, A M., Min, S., Molinier, P., Chastagnier, M , Claude, J. R., and Festy, B. Smokers' behavior and exposure according to cigarette yield and smoking experience. Pharmacol Biochem. Behavior, 52: 195-203, 1995.
32. Lewtas, J., Walsh, D., Williams, R , and Dobias, L. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutat. Res., 378: 51-63, 1997
33. 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers. In: D. H. Phillips, M Gastegnaro, and H. Bartsch (eds.), Postlabelling methods for detection of DNA adducts, pp. 331-340. Lyon, France IARC, 1993.
34. Vineis, P., Bartsch, H., Caporaso, N., Harrington, A. M., Kadlubar, F. F., Landi, M. T., Malaveille, C., Shields, P. G., Skipper, P , Talaska, O , and Tannenbaum, S. R. Genetically based N-acetyltransferase polymorphism and low-level environmental exposure to carcinogens. Nature (Lond.), 369: 154-156, 1994.